Fig. 7From: CDK1 serves as a therapeutic target of adrenocortical carcinoma via regulating epithelial–mesenchymal transition, G2/M phase transition, and PANoptosisThe role of CDK1 in ACC. CDK1 serves as a therapeutic target of adrenocortical carcinoma as a regulator of the epithelial-mesenchymal transition, G2/M phase, and PANoptosis. CurE is a probable candidate for the treatment of ACC by inhibiting CDK1Back to article page